NASDAQ · TVGN
Tevogen Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for TVGN: Nov 13, 2026
Tevogen Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-1.5.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · Quiver Quantitative- RTTNews · Oct 1, 2:56 AM EDTTevogen Regains Nasdaq Listing Compliance; Stock Up(RTTNews) – Tevogen Inc. (TVGN), a healthcare company, said it received notice from Nasdaq on September 29, 2026, confirming that it had regained compliance with the $50 million minimum market value of listed securities requirement for continued listing on the Nasdaq Global Marke
- RTTNews · Jul 27, 11:29 PM EDTTop Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired(RTTNews) – Today's top biotech gainers include Entera Bio, following an oversubscribed private placement financing; Gossamer, which is progressing toward a planned Seralutinib NDA submission in September; First Tracks, which has been firing on all cylinders since its Nasdaq debu
- RTTNews · May 29, 2:27 AM EDTTop Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest(RTTNews) – In Thursday's list of gainers, we highlight SciSparc, which received the regulatory go-ahead to acquire a stake in a private Israeli technology company, Co-Diagnostics, which extended its rally for the third straight day, and Tevogen, which is making continued progres
- RTTNews · May 29, 1:25 AM EDTTevogen Advances Strategic Acquisition Plans With Potential To Add $100 Million In Annual Revenue(RTTNews) – Tevogen Bio Holdings Inc. (TVGN) announced continued progress on a series of strategic acquisition initiatives that the company says could collectively support approximately $100 million in combined annual revenue, if completed. Shares of the company moved higher foll
- RTTNews · May 21, 3:52 PM EDTTevogen Signs LOI To Evaluate MSO Acquisition; Stock Up(RTTNews) – Tevogen Bio Holdings Inc. (TVGN), a healthcare enterprise integrating biotechnology and AI, announced it has signed a non-exclusive, non-binding Letter of Intent to evaluate a potential acquisition of Management Services Organization (MSO).
- RTTNews · Apr 28, 4:02 AM EDTTevogen.AI's PredicTcell Model Nears Completion As Company Begins Commercial Readiness Work(RTTNews) – Tevogen Bio Holdings Inc. (TVGN) says its proprietary AI model, PredicTcell is now approaching the final stages of training- a milestone the company describes as a key step toward future commercial deployment.
- Fintel · Mar 27, 12:06 AM EDTTevogen Bio Holdings (TVGN) Price Target Increased by 1,900.00% to 102.00The average one-year price target for Tevogen Bio Holdings (NasdaqGM:TVGN) has been revised to $102.00 / share. This is an increase of 1,900.00% from the prior estimate of $5.10 dated February 21, 2026. The price target is an average of many targets provided b
- RTTNews · Mar 4, 10:27 AM ESTTevogen Shares Plunge 22% After Reverse Stock Split Announcement(RTTNews) – Shares of Tevogen Bio Holdings Inc. (TVGN) fell 22% after the company announced a 50-for-1 reverse stock split of its common stock.
- Fintel · Nov 20, 7:07 PM ESTD. Boral Capital Maintains Tevogen Bio Holdings (TVGN) Buy RecommendationFintel reports that on November 20, 2025, D. Boral Capital maintained coverage of Tevogen Bio Holdings (NasdaqGM:TVGN) with a Buy recommendation. Analyst Price Forecast Suggests 2,359.02% Upside
- Quiver Quantitative · Jul 18, 12:40 PM EDTTevogen Bio Holdings Inc. Announces Publication of International Patent Application for AI-Driven Immunologically Active Peptide Prediction TechnologyTevogen's WIPO patent application details a machine learning approach for identifying immunologically active peptides to enhance targeted therapies.
- Quiver Quantitative · Jul 16, 12:00 PM EDTTevogen Bio Launches AI-Driven Tevogen.AI to Accelerate Clinical Trial Participation and Enhance ExacTcell™ Pipeline DevelopmentTevogen Bio expands AI-driven platform to improve clinical trial efficiency and accelerate therapy development for patients.
- Quiver Quantitative · Jul 14, 9:40 AM EDTTevogen.AI Launches PredicTcell Model to Transform Drug Discovery and Accelerate Cancer Immunotherapy DevelopmentTevogen.AI has launched PredicTcell™, reducing drug discovery timelines and costs, and expanding into oncology for cancer research.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Tevogen Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.